Consolidated Statements of Cash Flows - USD ($) $ in Thousands	12 Months Ended
	Jan. 31, 2022	Jan. 31, 2021	Jan. 31, 2020
Change in fair value of contingent earnout liability	$ (84,420)	$ 0	$ 0
Cash flows from operating activities
Net loss	(132,241)	(197,024)	(134,327)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization	16,457	10,083	7,698
Non-cash operating lease cost	4,244	3,762	3,121
Stock-based compensation	67,331	4,947	2,937
Amortization of deferred contract acquisition costs	1,786	1,206	675
Transaction costs expensed	7,031	0	0
Deferred tax benefit	(3,306)	0	0
Other	3,680	1,858	2,014
Changes in operating assets and liabilities, net of effect of acquisitions:
Accounts receivable, net	(38,388)	3,292	(8,702)
Inventories	(1,991)	(9,585)	(1,472)
Prepaid expenses and other assets	(23,941)	(8,914)	(2,961)
Operating lease liabilities	(3,460)	(2,815)	(1,181)
Accounts payable	7,933	(493)	15,704
Accrued and other liabilities	21,619	11,556	93
Deferred revenue	55,281	17,156	27,590
Net cash used in operating activities	(157,178)	(91,846)	(87,936)
Cash flows from investing activities
Purchases of property and equipment	(16,410)	(11,484)	(14,885)
Purchases of investments	0	0	(179,514)
Maturities of investments	0	47,014	132,500
Cash paid for acquisition, net of cash acquired	(205,330)	0	0
Net cash provided by (used in) investing activities	(221,740)	35,530	(61,899)
Cash flows from financing activities
Proceeds from issuance of redeemable convertible preferred stock	0	95,456	14,756
Proceeds from the exercise of public warrants	118,864	0	0
Merger and PIPE financing	511,646	0	0
Payment of tax withholding obligations on settlement of earnout shares	(20,895)	0	0
Repayment of borrowings	(36,051)	0	0
Proceeds from issuance of common stock warrants, net of issuance costs	0	31,547	185
Payments of transaction costs related to Merger	(32,468)	0	0
Change in driver funds and amounts due to customers	3,675	0	0
Payment of deferred transaction costs	0	(4,003)	0
Proceeds from issuance of stock in connection with stock plans, net of withholding taxes	4,916	5,913	2,217
Net cash provided by financing activities	549,687	128,913	17,158
Effect of exchange rate changes on cash, cash equivalents, and restricted cash	(1,025)	141	132
Net increase (decrease) in cash, cash equivalents, and restricted cash	169,744	72,738	(132,545)
Cash, cash equivalents, and restricted cash at beginning of period	145,891	73,153	205,698
Cash, cash equivalents, and restricted cash at end of period	315,635	145,891	73,153
Supplementary cash flow information
Cash paid for interest	346	2,801	3,414
Cash paid for taxes	268	172	153
Supplementary cash flow information on non-cash investing and financing activities
Accretion of beneficial conversion feature of redeemable convertible preferred stock	0	60,377	0
Deferred transaction costs not yet paid	0	1,685	0
Right-of-use assets obtained in exchange for lease liabilities	7,991	2,118	2,906
Right-of-use asset remeasurement subsequent to lease extension	0	12,867	0
Acquisitions of property and equipment included in accounts payable and accrued and other current liabilities	660	647	1,287
Vesting of early exercised stock options	178	268	15
Conversion of redeemable convertible preferred stock into common stock in connection with the reverse recapitalization	615,697	0	0
Reclassification of Legacy ChargePoint redeemable convertible preferred stock warrant liability upon the reverse capitalization	66,606	0	0
Contingent earnout liability recognized upon the closing of the reverse recapitalization	828,180	0	0
Reclassification of remaining contingent earnout liability upon triggering event	242,640	0	0
Issuance of common stock in connection with acquisitions	102,057	0	0
ViriCiti
Change in fair value of contingent earnout liability	2,266	0	0
Common stock warrant
Change in fair value of warrant liabilities	(47,822)	0	0
Redeemable convertible preferred stock warrant
Change in fair value of warrant liabilities	$ (9,237)	$ 73,125	$ 875